A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc.
University of Pittsburgh
Marengo Therapeutics, Inc.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Blokhin's Russian Cancer Research Center